Global Antiemetic Drugs Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-antiemetic-drugs-market-research-report-2023status-n-outlook_en.gif)
Report Overview:
An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.
The Global Antiemetic Drugs Market Size was estimated at USD 4994.03 million in 2023 and is projected to reach USD 6503.53 million by 2029, exhibiting a CAGR of 4.50% during the forecast period.
This report provides a deep insight into the global Antiemetic Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antiemetic Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antiemetic Drugs market in any manner.
Global Antiemetic Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Market Segmentation (by Type)
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist
Market Segmentation (by Application)
Chemotherapy
Gastroenteritis
Surgery
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiemetic Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.
The Global Antiemetic Drugs Market Size was estimated at USD 4994.03 million in 2023 and is projected to reach USD 6503.53 million by 2029, exhibiting a CAGR of 4.50% during the forecast period.
This report provides a deep insight into the global Antiemetic Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antiemetic Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antiemetic Drugs market in any manner.
Global Antiemetic Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Market Segmentation (by Type)
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist
Market Segmentation (by Application)
Chemotherapy
Gastroenteritis
Surgery
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Antiemetic Drugs Market
- Overview of the regional outlook of the Antiemetic Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antiemetic Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Antiemetic Drugs
1.2 Key Market Segments
1.2.1 Antiemetic Drugs Segment by Type
1.2.2 Antiemetic Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIEMETIC DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antiemetic Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antiemetic Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIEMETIC DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Antiemetic Drugs Sales by Manufacturers (2019-2024)
3.2 Global Antiemetic Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antiemetic Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antiemetic Drugs Sales Sites, Area Served, Product Type
3.6 Antiemetic Drugs Market Competitive Situation and Trends
3.6.1 Antiemetic Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antiemetic Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTIEMETIC DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Antiemetic Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIEMETIC DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTIEMETIC DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiemetic Drugs Sales Market Share by Type (2019-2024)
6.3 Global Antiemetic Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Antiemetic Drugs Price by Type (2019-2024)
7 ANTIEMETIC DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiemetic Drugs Market Sales by Application (2019-2024)
7.3 Global Antiemetic Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Antiemetic Drugs Sales Growth Rate by Application (2019-2024)
8 ANTIEMETIC DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Antiemetic Drugs Sales by Region
8.1.1 Global Antiemetic Drugs Sales by Region
8.1.2 Global Antiemetic Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Antiemetic Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antiemetic Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antiemetic Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antiemetic Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antiemetic Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Antiemetic Drugs Basic Information
9.1.2 GlaxoSmithKline Antiemetic Drugs Product Overview
9.1.3 GlaxoSmithKline Antiemetic Drugs Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Antiemetic Drugs SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 Johnson and Johnson
9.2.1 Johnson and Johnson Antiemetic Drugs Basic Information
9.2.2 Johnson and Johnson Antiemetic Drugs Product Overview
9.2.3 Johnson and Johnson Antiemetic Drugs Product Market Performance
9.2.4 Johnson and Johnson Business Overview
9.2.5 Johnson and Johnson Antiemetic Drugs SWOT Analysis
9.2.6 Johnson and Johnson Recent Developments
9.3 Pfizer
9.3.1 Pfizer Antiemetic Drugs Basic Information
9.3.2 Pfizer Antiemetic Drugs Product Overview
9.3.3 Pfizer Antiemetic Drugs Product Market Performance
9.3.4 Pfizer Antiemetic Drugs SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Sanofi
9.4.1 Sanofi Antiemetic Drugs Basic Information
9.4.2 Sanofi Antiemetic Drugs Product Overview
9.4.3 Sanofi Antiemetic Drugs Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 Abbott
9.5.1 Abbott Antiemetic Drugs Basic Information
9.5.2 Abbott Antiemetic Drugs Product Overview
9.5.3 Abbott Antiemetic Drugs Product Market Performance
9.5.4 Abbott Business Overview
9.5.5 Abbott Recent Developments
9.6 Bristol-Myers Squibb
9.6.1 Bristol-Myers Squibb Antiemetic Drugs Basic Information
9.6.2 Bristol-Myers Squibb Antiemetic Drugs Product Overview
9.6.3 Bristol-Myers Squibb Antiemetic Drugs Product Market Performance
9.6.4 Bristol-Myers Squibb Business Overview
9.6.5 Bristol-Myers Squibb Recent Developments
9.7 Cipla
9.7.1 Cipla Antiemetic Drugs Basic Information
9.7.2 Cipla Antiemetic Drugs Product Overview
9.7.3 Cipla Antiemetic Drugs Product Market Performance
9.7.4 Cipla Business Overview
9.7.5 Cipla Recent Developments
9.8 Eisai
9.8.1 Eisai Antiemetic Drugs Basic Information
9.8.2 Eisai Antiemetic Drugs Product Overview
9.8.3 Eisai Antiemetic Drugs Product Market Performance
9.8.4 Eisai Business Overview
9.8.5 Eisai Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly Antiemetic Drugs Basic Information
9.9.2 Eli Lilly Antiemetic Drugs Product Overview
9.9.3 Eli Lilly Antiemetic Drugs Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 Glenmark
9.10.1 Glenmark Antiemetic Drugs Basic Information
9.10.2 Glenmark Antiemetic Drugs Product Overview
9.10.3 Glenmark Antiemetic Drugs Product Market Performance
9.10.4 Glenmark Business Overview
9.10.5 Glenmark Recent Developments
9.11 Helsinn Healthcare
9.11.1 Helsinn Healthcare Antiemetic Drugs Basic Information
9.11.2 Helsinn Healthcare Antiemetic Drugs Product Overview
9.11.3 Helsinn Healthcare Antiemetic Drugs Product Market Performance
9.11.4 Helsinn Healthcare Business Overview
9.11.5 Helsinn Healthcare Recent Developments
9.12 Heron Therapeutics
9.12.1 Heron Therapeutics Antiemetic Drugs Basic Information
9.12.2 Heron Therapeutics Antiemetic Drugs Product Overview
9.12.3 Heron Therapeutics Antiemetic Drugs Product Market Performance
9.12.4 Heron Therapeutics Business Overview
9.12.5 Heron Therapeutics Recent Developments
9.13 IPCA Laboratories
9.13.1 IPCA Laboratories Antiemetic Drugs Basic Information
9.13.2 IPCA Laboratories Antiemetic Drugs Product Overview
9.13.3 IPCA Laboratories Antiemetic Drugs Product Market Performance
9.13.4 IPCA Laboratories Business Overview
9.13.5 IPCA Laboratories Recent Developments
9.14 Lupin
9.14.1 Lupin Antiemetic Drugs Basic Information
9.14.2 Lupin Antiemetic Drugs Product Overview
9.14.3 Lupin Antiemetic Drugs Product Market Performance
9.14.4 Lupin Business Overview
9.14.5 Lupin Recent Developments
9.15 Merck
9.15.1 Merck Antiemetic Drugs Basic Information
9.15.2 Merck Antiemetic Drugs Product Overview
9.15.3 Merck Antiemetic Drugs Product Market Performance
9.15.4 Merck Business Overview
9.15.5 Merck Recent Developments
9.16 Novartis
9.16.1 Novartis Antiemetic Drugs Basic Information
9.16.2 Novartis Antiemetic Drugs Product Overview
9.16.3 Novartis Antiemetic Drugs Product Market Performance
9.16.4 Novartis Business Overview
9.16.5 Novartis Recent Developments
9.17 RedHill
9.17.1 RedHill Antiemetic Drugs Basic Information
9.17.2 RedHill Antiemetic Drugs Product Overview
9.17.3 RedHill Antiemetic Drugs Product Market Performance
9.17.4 RedHill Business Overview
9.17.5 RedHill Recent Developments
9.18 Sun Pharmaceutical Industries
9.18.1 Sun Pharmaceutical Industries Antiemetic Drugs Basic Information
9.18.2 Sun Pharmaceutical Industries Antiemetic Drugs Product Overview
9.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Product Market Performance
9.18.4 Sun Pharmaceutical Industries Business Overview
9.18.5 Sun Pharmaceutical Industries Recent Developments
9.19 Takeda Pharmaceutical
9.19.1 Takeda Pharmaceutical Antiemetic Drugs Basic Information
9.19.2 Takeda Pharmaceutical Antiemetic Drugs Product Overview
9.19.3 Takeda Pharmaceutical Antiemetic Drugs Product Market Performance
9.19.4 Takeda Pharmaceutical Business Overview
9.19.5 Takeda Pharmaceutical Recent Developments
10 ANTIEMETIC DRUGS MARKET FORECAST BY REGION
10.1 Global Antiemetic Drugs Market Size Forecast
10.2 Global Antiemetic Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antiemetic Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Antiemetic Drugs Market Size Forecast by Region
10.2.4 South America Antiemetic Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antiemetic Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Antiemetic Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antiemetic Drugs by Type (2025-2030)
11.1.2 Global Antiemetic Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antiemetic Drugs by Type (2025-2030)
11.2 Global Antiemetic Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Antiemetic Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Antiemetic Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Antiemetic Drugs
1.2 Key Market Segments
1.2.1 Antiemetic Drugs Segment by Type
1.2.2 Antiemetic Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIEMETIC DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antiemetic Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antiemetic Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIEMETIC DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Antiemetic Drugs Sales by Manufacturers (2019-2024)
3.2 Global Antiemetic Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antiemetic Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antiemetic Drugs Sales Sites, Area Served, Product Type
3.6 Antiemetic Drugs Market Competitive Situation and Trends
3.6.1 Antiemetic Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antiemetic Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTIEMETIC DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Antiemetic Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIEMETIC DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTIEMETIC DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antiemetic Drugs Sales Market Share by Type (2019-2024)
6.3 Global Antiemetic Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Antiemetic Drugs Price by Type (2019-2024)
7 ANTIEMETIC DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antiemetic Drugs Market Sales by Application (2019-2024)
7.3 Global Antiemetic Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Antiemetic Drugs Sales Growth Rate by Application (2019-2024)
8 ANTIEMETIC DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Antiemetic Drugs Sales by Region
8.1.1 Global Antiemetic Drugs Sales by Region
8.1.2 Global Antiemetic Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Antiemetic Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antiemetic Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antiemetic Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antiemetic Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antiemetic Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Antiemetic Drugs Basic Information
9.1.2 GlaxoSmithKline Antiemetic Drugs Product Overview
9.1.3 GlaxoSmithKline Antiemetic Drugs Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Antiemetic Drugs SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 Johnson and Johnson
9.2.1 Johnson and Johnson Antiemetic Drugs Basic Information
9.2.2 Johnson and Johnson Antiemetic Drugs Product Overview
9.2.3 Johnson and Johnson Antiemetic Drugs Product Market Performance
9.2.4 Johnson and Johnson Business Overview
9.2.5 Johnson and Johnson Antiemetic Drugs SWOT Analysis
9.2.6 Johnson and Johnson Recent Developments
9.3 Pfizer
9.3.1 Pfizer Antiemetic Drugs Basic Information
9.3.2 Pfizer Antiemetic Drugs Product Overview
9.3.3 Pfizer Antiemetic Drugs Product Market Performance
9.3.4 Pfizer Antiemetic Drugs SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Sanofi
9.4.1 Sanofi Antiemetic Drugs Basic Information
9.4.2 Sanofi Antiemetic Drugs Product Overview
9.4.3 Sanofi Antiemetic Drugs Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 Abbott
9.5.1 Abbott Antiemetic Drugs Basic Information
9.5.2 Abbott Antiemetic Drugs Product Overview
9.5.3 Abbott Antiemetic Drugs Product Market Performance
9.5.4 Abbott Business Overview
9.5.5 Abbott Recent Developments
9.6 Bristol-Myers Squibb
9.6.1 Bristol-Myers Squibb Antiemetic Drugs Basic Information
9.6.2 Bristol-Myers Squibb Antiemetic Drugs Product Overview
9.6.3 Bristol-Myers Squibb Antiemetic Drugs Product Market Performance
9.6.4 Bristol-Myers Squibb Business Overview
9.6.5 Bristol-Myers Squibb Recent Developments
9.7 Cipla
9.7.1 Cipla Antiemetic Drugs Basic Information
9.7.2 Cipla Antiemetic Drugs Product Overview
9.7.3 Cipla Antiemetic Drugs Product Market Performance
9.7.4 Cipla Business Overview
9.7.5 Cipla Recent Developments
9.8 Eisai
9.8.1 Eisai Antiemetic Drugs Basic Information
9.8.2 Eisai Antiemetic Drugs Product Overview
9.8.3 Eisai Antiemetic Drugs Product Market Performance
9.8.4 Eisai Business Overview
9.8.5 Eisai Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly Antiemetic Drugs Basic Information
9.9.2 Eli Lilly Antiemetic Drugs Product Overview
9.9.3 Eli Lilly Antiemetic Drugs Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 Glenmark
9.10.1 Glenmark Antiemetic Drugs Basic Information
9.10.2 Glenmark Antiemetic Drugs Product Overview
9.10.3 Glenmark Antiemetic Drugs Product Market Performance
9.10.4 Glenmark Business Overview
9.10.5 Glenmark Recent Developments
9.11 Helsinn Healthcare
9.11.1 Helsinn Healthcare Antiemetic Drugs Basic Information
9.11.2 Helsinn Healthcare Antiemetic Drugs Product Overview
9.11.3 Helsinn Healthcare Antiemetic Drugs Product Market Performance
9.11.4 Helsinn Healthcare Business Overview
9.11.5 Helsinn Healthcare Recent Developments
9.12 Heron Therapeutics
9.12.1 Heron Therapeutics Antiemetic Drugs Basic Information
9.12.2 Heron Therapeutics Antiemetic Drugs Product Overview
9.12.3 Heron Therapeutics Antiemetic Drugs Product Market Performance
9.12.4 Heron Therapeutics Business Overview
9.12.5 Heron Therapeutics Recent Developments
9.13 IPCA Laboratories
9.13.1 IPCA Laboratories Antiemetic Drugs Basic Information
9.13.2 IPCA Laboratories Antiemetic Drugs Product Overview
9.13.3 IPCA Laboratories Antiemetic Drugs Product Market Performance
9.13.4 IPCA Laboratories Business Overview
9.13.5 IPCA Laboratories Recent Developments
9.14 Lupin
9.14.1 Lupin Antiemetic Drugs Basic Information
9.14.2 Lupin Antiemetic Drugs Product Overview
9.14.3 Lupin Antiemetic Drugs Product Market Performance
9.14.4 Lupin Business Overview
9.14.5 Lupin Recent Developments
9.15 Merck
9.15.1 Merck Antiemetic Drugs Basic Information
9.15.2 Merck Antiemetic Drugs Product Overview
9.15.3 Merck Antiemetic Drugs Product Market Performance
9.15.4 Merck Business Overview
9.15.5 Merck Recent Developments
9.16 Novartis
9.16.1 Novartis Antiemetic Drugs Basic Information
9.16.2 Novartis Antiemetic Drugs Product Overview
9.16.3 Novartis Antiemetic Drugs Product Market Performance
9.16.4 Novartis Business Overview
9.16.5 Novartis Recent Developments
9.17 RedHill
9.17.1 RedHill Antiemetic Drugs Basic Information
9.17.2 RedHill Antiemetic Drugs Product Overview
9.17.3 RedHill Antiemetic Drugs Product Market Performance
9.17.4 RedHill Business Overview
9.17.5 RedHill Recent Developments
9.18 Sun Pharmaceutical Industries
9.18.1 Sun Pharmaceutical Industries Antiemetic Drugs Basic Information
9.18.2 Sun Pharmaceutical Industries Antiemetic Drugs Product Overview
9.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Product Market Performance
9.18.4 Sun Pharmaceutical Industries Business Overview
9.18.5 Sun Pharmaceutical Industries Recent Developments
9.19 Takeda Pharmaceutical
9.19.1 Takeda Pharmaceutical Antiemetic Drugs Basic Information
9.19.2 Takeda Pharmaceutical Antiemetic Drugs Product Overview
9.19.3 Takeda Pharmaceutical Antiemetic Drugs Product Market Performance
9.19.4 Takeda Pharmaceutical Business Overview
9.19.5 Takeda Pharmaceutical Recent Developments
10 ANTIEMETIC DRUGS MARKET FORECAST BY REGION
10.1 Global Antiemetic Drugs Market Size Forecast
10.2 Global Antiemetic Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antiemetic Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Antiemetic Drugs Market Size Forecast by Region
10.2.4 South America Antiemetic Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antiemetic Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Antiemetic Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antiemetic Drugs by Type (2025-2030)
11.1.2 Global Antiemetic Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antiemetic Drugs by Type (2025-2030)
11.2 Global Antiemetic Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Antiemetic Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Antiemetic Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antiemetic Drugs Market Size Comparison by Region (M USD)
Table 5. Global Antiemetic Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Antiemetic Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antiemetic Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antiemetic Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiemetic Drugs as of 2022)
Table 10. Global Market Antiemetic Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antiemetic Drugs Sales Sites and Area Served
Table 12. Manufacturers Antiemetic Drugs Product Type
Table 13. Global Antiemetic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antiemetic Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antiemetic Drugs Market Challenges
Table 22. Global Antiemetic Drugs Sales by Type (Kilotons)
Table 23. Global Antiemetic Drugs Market Size by Type (M USD)
Table 24. Global Antiemetic Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Antiemetic Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Antiemetic Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Antiemetic Drugs Market Size Share by Type (2019-2024)
Table 28. Global Antiemetic Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Antiemetic Drugs Sales (Kilotons) by Application
Table 30. Global Antiemetic Drugs Market Size by Application
Table 31. Global Antiemetic Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Antiemetic Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Antiemetic Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Antiemetic Drugs Market Share by Application (2019-2024)
Table 35. Global Antiemetic Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Antiemetic Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Antiemetic Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Antiemetic Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Antiemetic Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Antiemetic Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Antiemetic Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Antiemetic Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. GlaxoSmithKline Antiemetic Drugs Basic Information
Table 44. GlaxoSmithKline Antiemetic Drugs Product Overview
Table 45. GlaxoSmithKline Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GlaxoSmithKline Business Overview
Table 47. GlaxoSmithKline Antiemetic Drugs SWOT Analysis
Table 48. GlaxoSmithKline Recent Developments
Table 49. Johnson and Johnson Antiemetic Drugs Basic Information
Table 50. Johnson and Johnson Antiemetic Drugs Product Overview
Table 51. Johnson and Johnson Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Johnson and Johnson Business Overview
Table 53. Johnson and Johnson Antiemetic Drugs SWOT Analysis
Table 54. Johnson and Johnson Recent Developments
Table 55. Pfizer Antiemetic Drugs Basic Information
Table 56. Pfizer Antiemetic Drugs Product Overview
Table 57. Pfizer Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Antiemetic Drugs SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Sanofi Antiemetic Drugs Basic Information
Table 62. Sanofi Antiemetic Drugs Product Overview
Table 63. Sanofi Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sanofi Business Overview
Table 65. Sanofi Recent Developments
Table 66. Abbott Antiemetic Drugs Basic Information
Table 67. Abbott Antiemetic Drugs Product Overview
Table 68. Abbott Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Abbott Business Overview
Table 70. Abbott Recent Developments
Table 71. Bristol-Myers Squibb Antiemetic Drugs Basic Information
Table 72. Bristol-Myers Squibb Antiemetic Drugs Product Overview
Table 73. Bristol-Myers Squibb Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Recent Developments
Table 76. Cipla Antiemetic Drugs Basic Information
Table 77. Cipla Antiemetic Drugs Product Overview
Table 78. Cipla Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Cipla Business Overview
Table 80. Cipla Recent Developments
Table 81. Eisai Antiemetic Drugs Basic Information
Table 82. Eisai Antiemetic Drugs Product Overview
Table 83. Eisai Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Eisai Business Overview
Table 85. Eisai Recent Developments
Table 86. Eli Lilly Antiemetic Drugs Basic Information
Table 87. Eli Lilly Antiemetic Drugs Product Overview
Table 88. Eli Lilly Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Recent Developments
Table 91. Glenmark Antiemetic Drugs Basic Information
Table 92. Glenmark Antiemetic Drugs Product Overview
Table 93. Glenmark Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Glenmark Business Overview
Table 95. Glenmark Recent Developments
Table 96. Helsinn Healthcare Antiemetic Drugs Basic Information
Table 97. Helsinn Healthcare Antiemetic Drugs Product Overview
Table 98. Helsinn Healthcare Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Helsinn Healthcare Business Overview
Table 100. Helsinn Healthcare Recent Developments
Table 101. Heron Therapeutics Antiemetic Drugs Basic Information
Table 102. Heron Therapeutics Antiemetic Drugs Product Overview
Table 103. Heron Therapeutics Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Heron Therapeutics Business Overview
Table 105. Heron Therapeutics Recent Developments
Table 106. IPCA Laboratories Antiemetic Drugs Basic Information
Table 107. IPCA Laboratories Antiemetic Drugs Product Overview
Table 108. IPCA Laboratories Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. IPCA Laboratories Business Overview
Table 110. IPCA Laboratories Recent Developments
Table 111. Lupin Antiemetic Drugs Basic Information
Table 112. Lupin Antiemetic Drugs Product Overview
Table 113. Lupin Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Lupin Business Overview
Table 115. Lupin Recent Developments
Table 116. Merck Antiemetic Drugs Basic Information
Table 117. Merck Antiemetic Drugs Product Overview
Table 118. Merck Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Merck Business Overview
Table 120. Merck Recent Developments
Table 121. Novartis Antiemetic Drugs Basic Information
Table 122. Novartis Antiemetic Drugs Product Overview
Table 123. Novartis Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Novartis Business Overview
Table 125. Novartis Recent Developments
Table 126. RedHill Antiemetic Drugs Basic Information
Table 127. RedHill Antiemetic Drugs Product Overview
Table 128. RedHill Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. RedHill Business Overview
Table 130. RedHill Recent Developments
Table 131. Sun Pharmaceutical Industries Antiemetic Drugs Basic Information
Table 132. Sun Pharmaceutical Industries Antiemetic Drugs Product Overview
Table 133. Sun Pharmaceutical Industries Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Sun Pharmaceutical Industries Business Overview
Table 135. Sun Pharmaceutical Industries Recent Developments
Table 136. Takeda Pharmaceutical Antiemetic Drugs Basic Information
Table 137. Takeda Pharmaceutical Antiemetic Drugs Product Overview
Table 138. Takeda Pharmaceutical Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Takeda Pharmaceutical Business Overview
Table 140. Takeda Pharmaceutical Recent Developments
Table 141. Global Antiemetic Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Antiemetic Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Antiemetic Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Antiemetic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Antiemetic Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Antiemetic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Antiemetic Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Antiemetic Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Antiemetic Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Antiemetic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Antiemetic Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Antiemetic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Antiemetic Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Antiemetic Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Antiemetic Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Antiemetic Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Antiemetic Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antiemetic Drugs Market Size Comparison by Region (M USD)
Table 5. Global Antiemetic Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Antiemetic Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antiemetic Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antiemetic Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiemetic Drugs as of 2022)
Table 10. Global Market Antiemetic Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antiemetic Drugs Sales Sites and Area Served
Table 12. Manufacturers Antiemetic Drugs Product Type
Table 13. Global Antiemetic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antiemetic Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antiemetic Drugs Market Challenges
Table 22. Global Antiemetic Drugs Sales by Type (Kilotons)
Table 23. Global Antiemetic Drugs Market Size by Type (M USD)
Table 24. Global Antiemetic Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Antiemetic Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Antiemetic Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Antiemetic Drugs Market Size Share by Type (2019-2024)
Table 28. Global Antiemetic Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Antiemetic Drugs Sales (Kilotons) by Application
Table 30. Global Antiemetic Drugs Market Size by Application
Table 31. Global Antiemetic Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Antiemetic Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Antiemetic Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Antiemetic Drugs Market Share by Application (2019-2024)
Table 35. Global Antiemetic Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Antiemetic Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Antiemetic Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Antiemetic Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Antiemetic Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Antiemetic Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Antiemetic Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Antiemetic Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. GlaxoSmithKline Antiemetic Drugs Basic Information
Table 44. GlaxoSmithKline Antiemetic Drugs Product Overview
Table 45. GlaxoSmithKline Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GlaxoSmithKline Business Overview
Table 47. GlaxoSmithKline Antiemetic Drugs SWOT Analysis
Table 48. GlaxoSmithKline Recent Developments
Table 49. Johnson and Johnson Antiemetic Drugs Basic Information
Table 50. Johnson and Johnson Antiemetic Drugs Product Overview
Table 51. Johnson and Johnson Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Johnson and Johnson Business Overview
Table 53. Johnson and Johnson Antiemetic Drugs SWOT Analysis
Table 54. Johnson and Johnson Recent Developments
Table 55. Pfizer Antiemetic Drugs Basic Information
Table 56. Pfizer Antiemetic Drugs Product Overview
Table 57. Pfizer Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer Antiemetic Drugs SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Sanofi Antiemetic Drugs Basic Information
Table 62. Sanofi Antiemetic Drugs Product Overview
Table 63. Sanofi Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sanofi Business Overview
Table 65. Sanofi Recent Developments
Table 66. Abbott Antiemetic Drugs Basic Information
Table 67. Abbott Antiemetic Drugs Product Overview
Table 68. Abbott Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Abbott Business Overview
Table 70. Abbott Recent Developments
Table 71. Bristol-Myers Squibb Antiemetic Drugs Basic Information
Table 72. Bristol-Myers Squibb Antiemetic Drugs Product Overview
Table 73. Bristol-Myers Squibb Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Recent Developments
Table 76. Cipla Antiemetic Drugs Basic Information
Table 77. Cipla Antiemetic Drugs Product Overview
Table 78. Cipla Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Cipla Business Overview
Table 80. Cipla Recent Developments
Table 81. Eisai Antiemetic Drugs Basic Information
Table 82. Eisai Antiemetic Drugs Product Overview
Table 83. Eisai Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Eisai Business Overview
Table 85. Eisai Recent Developments
Table 86. Eli Lilly Antiemetic Drugs Basic Information
Table 87. Eli Lilly Antiemetic Drugs Product Overview
Table 88. Eli Lilly Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Recent Developments
Table 91. Glenmark Antiemetic Drugs Basic Information
Table 92. Glenmark Antiemetic Drugs Product Overview
Table 93. Glenmark Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Glenmark Business Overview
Table 95. Glenmark Recent Developments
Table 96. Helsinn Healthcare Antiemetic Drugs Basic Information
Table 97. Helsinn Healthcare Antiemetic Drugs Product Overview
Table 98. Helsinn Healthcare Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Helsinn Healthcare Business Overview
Table 100. Helsinn Healthcare Recent Developments
Table 101. Heron Therapeutics Antiemetic Drugs Basic Information
Table 102. Heron Therapeutics Antiemetic Drugs Product Overview
Table 103. Heron Therapeutics Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Heron Therapeutics Business Overview
Table 105. Heron Therapeutics Recent Developments
Table 106. IPCA Laboratories Antiemetic Drugs Basic Information
Table 107. IPCA Laboratories Antiemetic Drugs Product Overview
Table 108. IPCA Laboratories Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. IPCA Laboratories Business Overview
Table 110. IPCA Laboratories Recent Developments
Table 111. Lupin Antiemetic Drugs Basic Information
Table 112. Lupin Antiemetic Drugs Product Overview
Table 113. Lupin Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Lupin Business Overview
Table 115. Lupin Recent Developments
Table 116. Merck Antiemetic Drugs Basic Information
Table 117. Merck Antiemetic Drugs Product Overview
Table 118. Merck Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Merck Business Overview
Table 120. Merck Recent Developments
Table 121. Novartis Antiemetic Drugs Basic Information
Table 122. Novartis Antiemetic Drugs Product Overview
Table 123. Novartis Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Novartis Business Overview
Table 125. Novartis Recent Developments
Table 126. RedHill Antiemetic Drugs Basic Information
Table 127. RedHill Antiemetic Drugs Product Overview
Table 128. RedHill Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. RedHill Business Overview
Table 130. RedHill Recent Developments
Table 131. Sun Pharmaceutical Industries Antiemetic Drugs Basic Information
Table 132. Sun Pharmaceutical Industries Antiemetic Drugs Product Overview
Table 133. Sun Pharmaceutical Industries Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Sun Pharmaceutical Industries Business Overview
Table 135. Sun Pharmaceutical Industries Recent Developments
Table 136. Takeda Pharmaceutical Antiemetic Drugs Basic Information
Table 137. Takeda Pharmaceutical Antiemetic Drugs Product Overview
Table 138. Takeda Pharmaceutical Antiemetic Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Takeda Pharmaceutical Business Overview
Table 140. Takeda Pharmaceutical Recent Developments
Table 141. Global Antiemetic Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global Antiemetic Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Antiemetic Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America Antiemetic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Antiemetic Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe Antiemetic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Antiemetic Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific Antiemetic Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Antiemetic Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America Antiemetic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Antiemetic Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Antiemetic Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Antiemetic Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global Antiemetic Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Antiemetic Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global Antiemetic Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global Antiemetic Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Antiemetic Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antiemetic Drugs Market Size (M USD), 2019-2030
Figure 5. Global Antiemetic Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Antiemetic Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antiemetic Drugs Market Size by Country (M USD)
Figure 11. Antiemetic Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Antiemetic Drugs Revenue Share by Manufacturers in 2023
Figure 13. Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antiemetic Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antiemetic Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antiemetic Drugs Market Share by Type
Figure 18. Sales Market Share of Antiemetic Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Antiemetic Drugs by Type in 2023
Figure 20. Market Size Share of Antiemetic Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Antiemetic Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antiemetic Drugs Market Share by Application
Figure 24. Global Antiemetic Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Antiemetic Drugs Sales Market Share by Application in 2023
Figure 26. Global Antiemetic Drugs Market Share by Application (2019-2024)
Figure 27. Global Antiemetic Drugs Market Share by Application in 2023
Figure 28. Global Antiemetic Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antiemetic Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Antiemetic Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Antiemetic Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Antiemetic Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Antiemetic Drugs Sales Market Share by Country in 2023
Figure 37. Germany Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Antiemetic Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Antiemetic Drugs Sales Market Share by Region in 2023
Figure 44. China Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Antiemetic Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Antiemetic Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Antiemetic Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Antiemetic Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Antiemetic Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Antiemetic Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antiemetic Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antiemetic Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Antiemetic Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Antiemetic Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Antiemetic Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antiemetic Drugs Market Size (M USD), 2019-2030
Figure 5. Global Antiemetic Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Antiemetic Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antiemetic Drugs Market Size by Country (M USD)
Figure 11. Antiemetic Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Antiemetic Drugs Revenue Share by Manufacturers in 2023
Figure 13. Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antiemetic Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antiemetic Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antiemetic Drugs Market Share by Type
Figure 18. Sales Market Share of Antiemetic Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Antiemetic Drugs by Type in 2023
Figure 20. Market Size Share of Antiemetic Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Antiemetic Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antiemetic Drugs Market Share by Application
Figure 24. Global Antiemetic Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Antiemetic Drugs Sales Market Share by Application in 2023
Figure 26. Global Antiemetic Drugs Market Share by Application (2019-2024)
Figure 27. Global Antiemetic Drugs Market Share by Application in 2023
Figure 28. Global Antiemetic Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antiemetic Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Antiemetic Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Antiemetic Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Antiemetic Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Antiemetic Drugs Sales Market Share by Country in 2023
Figure 37. Germany Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Antiemetic Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Antiemetic Drugs Sales Market Share by Region in 2023
Figure 44. China Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Antiemetic Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Antiemetic Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Antiemetic Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Antiemetic Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Antiemetic Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Antiemetic Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Antiemetic Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antiemetic Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antiemetic Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Antiemetic Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Antiemetic Drugs Market Share Forecast by Application (2025-2030)